Target intelligence / Profile preview

Molybdenum cofactor biosynthesis pathway enzymes

Molecular classification
Enzyme
01

Overview

Molybdenum cofactor biosynthesis enzymes comprise a sequence of highly conserved proteins responsible for synthesizing the pterin-based molybdenum cofactor (Moco), which is vital for the activity of all molybdenum-dependent oxidoreductases. In plants and mammals, these include enzymes such as CNX1, CNX2, CNX3, and in bacteria, MogA and MoeA, among others. The biosynthesis is a complex, multi-step pathway involving the formation of molybdopterin, its adenylation, and insertion of molybdenum, typically carried out by dedicated enzymatic complexes often associated with cytoskeletal structures for efficient substrate channelling. Defects in genes encoding these enzymes are responsible for rare but severe inherited metabolic diseases[1][2][3][4]. The pathway itself is not a direct drug target, but understanding its biology is essential for managing Moco deficiency disorders.

Other names
Moco biosynthesis enzymesCNX proteinsCNX1CNX2CNX3CNX5CNX6CNX7MogAMoeA
02

Biological functions

Molybdenum cofactor biosynthesisInsertion of molybdenum into pterin backboneProtection and transfer of sensitive intermediates within cells
03

Disease associations

Inherited Moco deficiency (genetic defects in individual enzymes)Possible involvement in rare inborn errors of metabolismOther (nutrient and redox disorders; limited direct disease targeting)
04

Safety considerations

Genetic or enzyme deficiencies can cause severe, often fatal, metabolic disorders due to failure to produce functional Mo-enzymesThe biosynthetic pathway is essential for life; inhibition may have broad toxic effects

Beyond the preview

Go deeper on Molybdenum cofactor biosynthesis pathway enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molybdenum cofactor biosynthesis pathway enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call